HAYA Therapeutics

Q: What industry does HAYA Therapeutics belong to?

HAYA Therapeutics is in the industry of: Business Services , Research & Development

Business Services · Switzerland · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Route De La Corniche Batiment Alanine 5b...

Website

www.hayatx.com

Revenue

$7 Million

Industry

Business Services

Research & Development

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About HAYA Therapeutics

HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company is headquartered in Lausanne, Switzerland.Explore more

Is this data correct?

View contact profiles from HAYA Therapeutics

Popular SearchesHaya Therapeutics SAHAYA TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

HAYA Therapeutics Org Chart

Phone

David Catherman

Manager, Information Technology

Phone

Get the full picture

Is HAYA Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Congratulate Masked Content for being promoted to Masked Content at HAYA Therapeutics

Click to see if HAYA Therapeutics had a recent Job posting/layoffs

Check if HAYA Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Earning: See what the market has to say on HAYA Therapeutics recently announced quarterly report

HAYA Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Check out if HAYA Therapeutics is spiking on competitors!

Product Launch: Get notified when HAYA Therapeutics launches new products

Website visits: Recent activity has been detected on your website

Funding: Get notified immidiatlly once HAYA Therapeutics has new funding data

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Recommended Actions

Introduce yourself to Masked Content, who has shown a strong intent to purchase lately

Find 3 more new buyers

View Email Formats for HAYA Therapeutics

Among all Business Services companies

Low Activity

High Activity

Activity Insights

HAYA Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

HAYA Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HAYA Therapeutics.

HAYA Therapeutics financials insights

Gather financial insights about HAYA Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2022

Angel/Seed

$25M

2025

Series A

$65M

See All HAYA Therapeutics's Financials Insights

HAYA Therapeutics Tech Stack

A closer look at the technologies used by HAYA Therapeutics

PHP

Python Software Foundation

See more technologies

Most Recent Scoops

Open Position

HAYA Therapeutics is currently seeking a Director, CMC (Therapeutic Oligonucleotides). (San Diego, California, United States)

Open Position

HAYA Therapeutics is currently seeking a Director, CMC (Therapeutic Oligonucleotides). (San Diego, California, United States)

Event

Samir Ounzain has been announced as a speaker for the BIO 2025 conference. The event will occur from June 16 to June 19, 2025 in San Diego, California.

Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience

Funding

HAYA Therapeutics has secured $65 million in Series A funding. The round was co-led by investors Earlybird Venture Capital and Sofinnova Partners, with participation from Longview Ventures, Eli Lilly, and others.

Funding

Open Position

See more scoops